 Altimmune, Inc. is a clinical-stage biopharmaceutical company developing intranasal vaccines, immune-modulating therapies, and treatments for liver disease. Altimmunes pipeline consists of intranasal vaccines for COVID-19, anthrax, and influenza; an intranasal immune modulating therapeutic for COVID-19; and next-generation peptide therapeutics for non-alcoholic steatohepatitis and chronic hepatitis b. 